LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes

International Journal of Dermatology

Volumn 47, Issue 5, 2008, Pages 457-462

  Rodríguez Martínez, Sandra ^a   Cancino Diaz, Juan Carlos ^a   Vargas Zuñiga, Luis Martin ^a   Cancino Diaz, Mario Eugenio ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INHIBITOR OF APOPTOSIS PROTEIN 2; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HACAT CELL; HUMAN; HUMAN CELL; KERATINOCYTE; LIPOSOMAL GENE DELIVERY SYSTEM; MOLECULAR CLONING; NONHUMAN; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, CATALYTIC; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INHIBITOR OF APOPTOSIS PROTEINS; KERATINOCYTES; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42449090687     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03340.x     Document Type: Article

References (30)

1. Gudmundsson GH, Magnusson KP, Chowdhary B, et al. Structure of the gene for porcine peptide antibiotic PR39, a cathelin gene family member. Comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc Natl Acad Sci USA 1995; 92: 7085-7089.
2. Travis SM, Anderson NN, Forsyth WR, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000; 68: 2748-2755.
3. Larrick JW, Hirata M, Balint RF, et al. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995; 63: 1291-1297.
4. De Yang, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192: 1069-1074.
5. Niyonsaba F, Hirata M, Ogawa H, et al. Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. Curr Drug Targets Inflamm Allergy 2003; 2: 224-231.
6. Heilborn JD, Nilsson MF, Kratz G, et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003; 120: 379-389.
7. Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 2000; 55: 31-49.
8. Li J, Post M, Volk R, et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000; 6: 49-55.
9. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 1998; 394: 485-490.
10. Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but no Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997; 272: 23, 659-23, 667.
11. Salceda S, Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 1997; 272: 22, 642-22, 647.
12. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998; 95: 7987-7992.
13. Kallio PJ, Wilson WJ, Makino OS, et al. Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999; 274: 619-625.
14. Wu J, Parungo C, Wu G, et al. PR39 inhibits apoptosis in hypoxic endothelial cells: Role of inhibitor apoptosis protein-2. Circulation 2004; 109: 1660-1667.
15. Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP18. J Clin Invest 2003; 111: 1665-1672.
16. Tovar-Castillo LE, Cancino-Díaz JC, García-Vázquez F, et al. Under-expression of VHL and over-expression of HDAC1, HIF-1alpha, LL-37 and IAP-2 in affected skin biopsies of patients with psoriasis. Int J Dermatol 2007; 46: 239-246.
17. Frohm M, Agerberth B, Ahangari G, et al. The expression of the gene coding for antibacterial peptide LL37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272: 15, 258-15, 263.
18. Ong PY, Ohtake T, Brandt C, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002; 347: 1151-1160.
19. Santero SW, Joyce GF. A general purpose RNA-cleaving DNAzyme. Proc Natl Acad Sci USA 1997; 94: 4262-4266.
20. Shinnar AE, Butler KL, Park HJ. Cathelicidin family of antimicrobial peptides; proteolytic processing and protease resistance. Bioorg Chem 2003; 31: 425-436.
21. Ellis RE, Yuan JY, Horvitz RA. Mechanisms and function of cell death. Annu Rev Cell Biol 1991; 7: 663-698.
22. Mallbris L, Larsson P, Bergqvist S, et al. Psoriasis phenotype at disease onset: Clinical characterization of 400 adult cases. J Invest Dermatol 2005; 124: 499-504.
23. Favre M, Orth G, Majewski S, et al. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311-317.
24. Majewski S, Jablonska S. Possible involvement of epidermodysplasia verruciformis human papillomaviruses in the immunopathogenesis of psoriasis: A proposed hypothesis. Exp Dermatol 2003; 12: 721-728.
25. Simeone P, Teson M, Latini A, et al. Human papillomavirus type 5 in primary keratinocytes from psoriatic skin. Exp Dermatol 2005; 14: 824-829.
26. Yuan H, Fu F, Zhuo J, et al. Human papillomavirus type 16, E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 2005; 24: 5069-5078.
27. Conner K, Nern K, Rudisill J, et al. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatun and verruca vulgaris. J Am Acad Dermatol 2002; 47: 347-350.
28. Okumura K, Itoh A, Isogai E, et al. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett 2004; 212: 185-194.
29. Barlow PG, Li Y, Wilkinson TS, et al. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 2006; 6: 22.
30. Fahmy RG, Dass CR, Sun LQ, et al. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9: 1026-1032.